Home › Stocks › VRDN › All Fund Holders
VRDN — VIRIDIAN THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 41 · Reported value held: $927.29M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 16.60M | $305.03M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 5.61M | $174.65M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 3.13M | $57.47M | 0.01% | Add |
| Maverick Capital history | Q3 2025 | 2.21M | $47.75M | 0.64% | Reduce |
| Geode Capital Management history | Q2 2026 | 2.50M | $45.97M | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 2.36M | $43.28M | 0.05% | Add |
| Goldman Sachs Group history | Q2 2026 | 1.69M | $31.07M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 1.43M | $26.25M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 1.28M | $23.51M | 0.03% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 1.11M | $20.44M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 944.35K | $17.35M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 863.49K | $15.86M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 14.25M | $15.29M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 815.03K | $14.97M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 768.60K | $14.12M | 0.02% | Add |
| Morgan Stanley history | Q2 2026 | 728.82K | $13.39M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 482.88K | $8.87M | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 6.05M | $6.48M | 0.00% | Reduce |
| Marshall Wace history | Q1 2026 | 269.59K | $5.27M | 0.01% | Reduce |
| BNY Mellon history | Q2 2026 | 268.06K | $4.92M | 0.00% | Add |
| Moore Capital Management history | Q4 2025 | 150.00K | $4.67M | 0.07% | New |
| Citadel Advisors history | Q2 2026 | 211.60K | $3.89M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2025 | 122.79K | $3.82M | 0.00% | New |
| Manulife Financial history | Q2 2026 | 180.35K | $3.31M | 0.00% | Add |
| Franklin Resources history | Q2 2022 | 250.00K | $2.89M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 140.41K | $2.58M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 2.25M | $2.41M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 127.30K | $2.34M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 115.56K | $2.12M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 100.89K | $1.85M | 0.00% | Reduce |
| Principal Global Investors history | Q1 2026 | 75.20K | $1.47M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 64.79K | $1.19M | 0.00% | Add |
| Davidson Kempner Capital Management history | Q2 2026 | 1.00M | $1.07M | 0.01% | New |
| Two Sigma Investments history | Q1 2026 | 35.11K | $686.83K | 0.00% | New |
| Janus Henderson Group history | Q1 2026 | 27.47K | $536.67K | 0.00% | Hold |
| Prudential Financial history | Q2 2026 | 14.77K | $271.32K | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 100.00K | $105.61K | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 5.75M | $105.60K | 0.01% | Add |
| Lazard Asset Management history | Q2 2026 | 2.00M | $21.51K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 222 | $4.08K | 0.00% | Add |
| Amundi US history | Q1 2025 | 83 | $1.05K | 0.00% | Add |